Clinical Trials Browser

Interventional × Losartan × 1 year × Clear all

NCT06211335 2026-03-12

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Phase 1 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03900793 2026-02-03

Losartan + Sunitinib in Treatment of Osteosarcoma

Phase 1 Recruiting

Osteosarcoma

NCT07265739 2025-12-11

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Phase 2 Not yet recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT05077800 2025-11-18

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT03563248 2025-10-01

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07160361 2025-09-16

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

Phase 4 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06135493 2025-04-24

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Peripheral Nervous System Diseases

NCT05365893 2025-04-16

PHL Treatment in Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04106856 2025-04-06

SHAPER

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms